Genetically encoded sensors for in vivo detection of neurochemicals relevant to depression
- PMID: 38468468
- DOI: 10.1111/jnc.16046
Genetically encoded sensors for in vivo detection of neurochemicals relevant to depression
Abstract
Depressive disorders are a common and debilitating form of mental illness with significant impacts on individuals and society. Despite the high prevalence, the underlying causes and mechanisms of depressive disorders are still poorly understood. Neurochemical systems, including serotonin, norepinephrine, and dopamine, have been implicated in the development and perpetuation of depressive symptoms. Current treatments for depression target these neuromodulator systems, but there is a need for a better understanding of their role in order to develop more effective treatments. Monitoring neurochemical dynamics during depressive symptoms is crucial for gaining a better a understanding of their involvement in depressive disorders. Genetically encoded sensors have emerged recently that offer high spatial-temporal resolution and the ability to monitor neurochemical dynamics in real time. This review explores the neurochemical systems involved in depression and discusses the applications and limitations of current monitoring tools for neurochemical dynamics. It also highlights the potential of genetically encoded sensors for better characterizing neurochemical dynamics in depression-related behaviors. Furthermore, potential improvements to current sensors are discussed in order to meet the requirements of depression research.
Keywords: depression; genetically‐encoded sensor; neurochemical.
© 2024 International Society for Neurochemistry.
References
REFERENCES
-
- Abdelfattah, A. S., Kawashima, T., Singh, A., Novak, O., Liu, H., Shuai, Y., Huang, Y., Campagnola, L., Seeman, S. C., Yu, J., Zheng, J., Grimm, J. B., Patel, R., Friedrich, J., Mensh, B. D., Paninski, L., Macklin, J. J., Murphy, G. J., Podgorski, K., … Schreiter, E. R. (2019). Bright and photostable chemigenetic indicators for extended in vivo voltage imaging. Science, 16(265), 699–704.
-
- Abdelfattah, A. S., Zheng, J., Singh, A., Huang, Y. C., Reep, D., Tsegaye, G., Tsang, A., Arthur, B. J., Rehorova, M., Olson, C. V. L., Shuai, Y., Zhang, L., Fu, T. M., Milkie, D. E., Moya, M. V., Weber, T. D., Lemire, A. L., Baker, C. A., Falco, N., … Kolb, I. (2023). Sensitivity optimization of a rhodopsin‐based fluorescent voltage indicator. Neuron, 111(10), 1547–1563. e1549. https://doi.org/10.1016/j.neuron.2023.03.009
-
- Abraham, H. D., & Fava, M. (1999). Order of onset of substance abuse and depression in a sample of depressed outpatients. Comprehensive Psychiatry, 40, 44–50.
-
- Aggarwal, A., Liu, R., Chen, Y., Ralowicz, A. J., Bergerson, S. J., Tomaska, F., Mohar, B., Hanson, T. L., Hasseman, J. P., Reep, D., Tsegaye, G., Yao, P., Ji, X., Kloos, M., Walpita, D., Patel, R., Mohr, M. A., Tillberg, P. W., Looger, L. L., … Podgorski, K. (2023). Glutamate indicators with improved activation kinetics and localization for imaging synaptic transmission. Nature Methods, 20(6), 925–934. https://doi.org/10.1038/s41592‐023‐01863‐6
-
- American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM‐5). American Psychiatric Publishing.
Publication types
MeSH terms
Substances
Grants and funding
- State Key Laboratory of Membrane Biology at Peking University School of Life Sciences
- Peking-Tsinghua Center for Life Sciences
- Z220009/Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
- 1U01NS113358/NIH BRAIN Initiative
- 1U01NS120824/NIH BRAIN Initiative
LinkOut - more resources
Full Text Sources
